Shares Of Array Biopharma Soared As Much As 40% On News Of Novartis Deal

ARRY stock popped on news that It would acquire a late-stage cancer compound known as encorafenib.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.